Show simple item record

dc.contributor.authorAllan, Ernest
dc.date.accessioned2014-12-22T15:11:34Z
dc.date.available2014-12-22T15:11:34Z
dc.date.issued1983
dc.identifier.citationCalcitonin in the treatment of intractable pain from advanced malignancy. 1983, 3 (7):482-6 Pharmatherapeuticaen
dc.identifier.issn0308-051X
dc.identifier.pmid6669591
dc.identifier.urihttp://hdl.handle.net/10541/337512
dc.description.abstractClinical details are given of 8 patients who complained of severe pain from metastatic bone disease or from multiple myeloma. Four of the patients were included in a double-blind pilot trial designed to compare the effectiveness of salmon calcitonin (200 i.u. intramuscularly) and placebo given twice daily for 4 days. Two of these patients experienced pain relief and were found to have been given salmon calcitonin; the other 2 had no pain relief and had been given placebo. The other 4 of the 8 patients were treated with salmon calcitonin and also had relief of their pain. It would appear, therefore, that salmon calcitonin may be dramatically effective in the treatment of intractable pain from advanced malignancy and its use warrants further study.
dc.language.isoenen
dc.rightsArchived with thanks to Pharmatherapeuticaen
dc.subject.meshBone Neoplasms
dc.subject.meshCalcitonin
dc.subject.meshDouble-Blind Method
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMultiple Myeloma
dc.subject.meshPain, Intractable
dc.subject.meshPilot Projects
dc.titleCalcitonin in the treatment of intractable pain from advanced malignancy.en
dc.typeArticleen
dc.contributor.departmentChristie Hospital, Manchesteren
dc.identifier.journalPharmatherapeuticaen
html.description.abstractClinical details are given of 8 patients who complained of severe pain from metastatic bone disease or from multiple myeloma. Four of the patients were included in a double-blind pilot trial designed to compare the effectiveness of salmon calcitonin (200 i.u. intramuscularly) and placebo given twice daily for 4 days. Two of these patients experienced pain relief and were found to have been given salmon calcitonin; the other 2 had no pain relief and had been given placebo. The other 4 of the 8 patients were treated with salmon calcitonin and also had relief of their pain. It would appear, therefore, that salmon calcitonin may be dramatically effective in the treatment of intractable pain from advanced malignancy and its use warrants further study.


This item appears in the following Collection(s)

Show simple item record